Regenerative Medical Technology Group Inc.
RMTG
$0.0254
-$0.0212-45.49%
OTC PK
03/31/2025 | 12/31/2024 | ||||
---|---|---|---|---|---|
Revenue | -9.70% | 53.18% | |||
Total Other Revenue | -- | -- | |||
Total Revenue | -9.70% | 53.18% | |||
Cost of Revenue | -20.77% | 121.82% | |||
Gross Profit | -3.70% | 31.20% | |||
SG&A Expenses | 21.14% | -1.61% | |||
Depreciation & Amortization | 286.33% | -131.31% | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | 9.00% | 17.09% | |||
Operating Income | -64.75% | 1,558.01% | |||
Income Before Tax | -19.08% | 28.06% | |||
Income Tax Expenses | -- | -- | |||
Earnings from Continuing Operations | -19.08% | 28.06% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | -19.08% | 28.06% | |||
EBIT | -64.75% | 1,558.01% | |||
EBITDA | -57.36% | 291.51% | |||
EPS Basic | -19.06% | 28.11% | |||
Normalized Basic EPS | -19.18% | 28.05% | |||
EPS Diluted | -19.06% | 28.11% | |||
Normalized Diluted EPS | -19.18% | 28.05% | |||
Average Basic Shares Outstanding | 0.00% | 0.00% | |||
Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |